Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats


Autoria(s): Holzhausen, M.; Spolidório, Luis Carlos; Vergnolle, N.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/02/2005

Resumo

Proteinase-activated receptor-2 (PAR2) is a G-protein-coupled receptor that mediates cellular responses to extracellular proteinases. Since PAR2 is expressed by oral epithelial cells, osteoblasts, and gingival fibroblasts, where its activation releases interleukin-8, we hypothesized that PAR2 activation may participate in periodontal disease in vivo. We investigated the role of PAR2 activation in periodontal disease in rats. Radiographic and enzymatic (myeloperoxidase) analysis revealed that topical application of PAR2 agonist causes periodontitis but also exacerbates existing periodontitis, leading to significant alveolar bone loss and gingival granulocyte infiltration. Inhibition of matrix metalloproteinase (MMP) and cyclo-oxygenase (COX) decreased PAR2 agonist-induced periodontitis. More specifically, the overexpression of COX-1, COX-2, MMP-2, and MMP-9 in gingival tissues suggests that they are involved in PAR 2-induced periodontitis. In conclusion, PAR2 agonist causes periodontitis in rats through a mechanism involving prostaglandin release and MMP activation. Inhibition of PAR2 may represent a novel approach to modulate host response in periodontitis.

Formato

154-159

Identificador

http://dx.doi.org/10.1177/154405910508400209

Journal of Dental Research, v. 84, n. 2, p. 154-159, 2005.

0022-0345

http://hdl.handle.net/11449/68126

10.1177/154405910508400209

WOS:000226834200009

2-s2.0-15544371471

Idioma(s)

eng

Relação

Journal of Dental Research

Direitos

closedAccess

Palavras-Chave #Alveolar bone loss #Cyclo-oxygenase #Inflammation #Matrix metalloproteinase #Periodontitis #Proteinase-activated receptor-2 #enzyme inhibitor #matrix metalloproteinase #oligopeptide #prostaglandin synthase #proteinase activated receptor 2 #seryl leucyl isoleucyl glycyl arginyl leucinamide #seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide #analysis of variance #animal #chemically induced disorder #comparative study #drug effect #drug potentiation #gingiva #granulocyte #immunology #male #metabolism #osteolysis #periodontitis #randomization #rat #Wistar rat #Alveolar Bone Loss #Analysis of Variance #Animals #Enzyme Inhibitors #Gingiva #Granulocytes #Male #Matrix Metalloproteinases #Oligopeptides #Prostaglandin-Endoperoxide Synthases #Random Allocation #Rats #Rats, Wistar #Receptor, PAR-2
Tipo

info:eu-repo/semantics/article